bf/NASDAQ:ALNY_icon.jpeg

NASDAQ:ALNY

Alnylam Pharmaceuticals, Inc.

  • Stock

USD

Last Close

147.89

15/05 20:00

Market Cap

22.54B

Beta: 0.48

Volume Today

536.14K

Avg: 846.05K

PE Ratio

−42.10

PFCF: −323.22

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
12.03M
-
40.21M
234.12%
74.33M
84.85%
107.50M
44.64%
125.83M
17.05%
109.05M
13.33%
average payables
5.16M
-
10.50M
103.64%
15.95M
51.84%
35.63M
123.37%
41.41M
16.24%
44.03M
6.33%
54.80M
24.45%
50.92M
7.06%
62.70M
23.11%
85.76M
36.79%
76.81M
10.44%
average receivables
2.18M
-
22.09M
915.28%
24.12M
9.17%
15.82M
34.42%
28.67M
81.26%
26.38M
7.98%
30.89M
17.07%
72.71M
135.42%
150.49M
106.97%
218.27M
45.04%
282.88M
29.60%
book value per share
4.39
-
12.60
186.98%
15.06
19.46%
10.75
28.60%
19.51
81.45%
12.94
33.65%
13.17
1.73%
8.84
32.88%
4.97
43.81%
-1.30
126.18%
-1.77
35.86%
capex per share
-0.07
-
-0.12
85.36%
-0.15
27.80%
-0.75
389.17%
-1.15
52.58%
-1.26
9.61%
-1.28
1.69%
-0.61
52.30%
-0.64
5.37%
-0.59
8.16%
-0.50
15.89%
capex to depreciation
-0.39
-
-0.75
91.86%
-0.68
9.53%
-4.27
527.67%
-7.80
82.71%
-19.72
152.93%
-2.58
86.93%
-0.95
63.33%
-0.85
9.92%
-0.84
1.08%
-1.15
36.64%
capex to operating cash flow
0.06
-
0.05
7.28%
0.07
26.56%
0.21
206.43%
0.27
29.76%
0.23
17.16%
0.50
123.20%
0.11
77.27%
0.12
4.02%
0.13
11.86%
-0.60
548.65%
capex to revenue
-0.08
-
-0.18
108.67%
-0.32
77.79%
-1.37
334.43%
-1.16
15.33%
-1.69
46.15%
-0.64
62.35%
-0.14
77.62%
-0.09
36.64%
-0.07
23.21%
-0.03
51.01%
cash per share
3.99
-
13.15
229.11%
15.86
20.66%
7.32
53.84%
18.67
154.95%
10.78
42.27%
14.06
30.44%
16.30
15.95%
20.56
26.14%
18.02
12.38%
19.53
8.40%
days of inventory on hand
4.88K
-
820.65
83.17%
431.64
47.40%
319.57
25.96%
278.83
12.75%
104.82
62.41%
days payables outstanding
12.09K
-
726.50
93.99%
243.01
66.55%
191.24
21.31%
212.09
10.90%
65.28
69.22%
days sales outstanding
32.87
-
288.31
777.03%
73.70
74.44%
180.60
145.05%
138.03
23.57%
91.41
33.78%
71.44
21.85%
75.85
6.17%
85.85
13.18%
83.72
2.47%
65.44
21.84%
debt to assets
0.01
-
-0.02
454.98%
0.00
119.66%
0.13
2,533.95%
0.02
83.94%
0.06
187.15%
0.24
310.53%
0.15
36.82%
0.27
79.00%
0.37
35.96%
0.64
71.10%
debt to equity
0.01
-
-0.03
363.14%
0.01
118.70%
0.18
3,197.03%
0.02
86.78%
0.07
207.57%
0.40
465.04%
0.51
27.22%
1.70
230.70%
-8.34
591.99%
-11.06
32.50%
dividend yield
earnings yield
-0.02
-
-0.05
121.87%
-0.04
26.66%
-0.13
248.83%
-0.04
66.66%
-0.10
143.35%
-0.07
32.18%
-0.06
18.44%
-0.04
26.07%
-0.04
7.87%
-0.02
52.92%
enterprise value
3.90B
-
6.32B
61.94%
6.63B
4.79%
3.16B
52.29%
10.89B
244.49%
6.94B
36.23%
12.34B
77.72%
14.97B
21.30%
20.26B
35.37%
29.37B
44.95%
25.78B
12.24%
enterprise value over ebitda
-42.01
-
172.99
511.77%
-22.38
112.94%
-7.45
66.74%
-21.78
192.48%
-8.31
61.82%
-13.14
58.01%
-19.41
47.78%
-28.58
47.21%
-32.84
14.92%
-113.00
244.10%
ev to operating cash flow
-56.87
-
-38.17
32.88%
-35.03
8.23%
-10.27
70.68%
-28.45
176.91%
-12.34
56.62%
-44.32
259.12%
-24.34
45.08%
-31.58
29.73%
-54.27
71.84%
247.50
556.07%
ev to sales
82.78
-
125.06
51.07%
161.23
28.92%
67.03
58.43%
121.11
80.68%
92.70
23.46%
56.16
39.42%
30.37
45.91%
24.00
20.98%
28.31
17.96%
14.10
50.20%
free cash flow per share
-1.18
-
-2.35
99.12%
-2.41
2.36%
-4.35
80.75%
-5.38
23.66%
-6.85
27.46%
-3.83
44.11%
-5.96
55.58%
-6.06
1.71%
-5.04
16.86%
0.34
106.66%
free cash flow yield
-0.02
-
-0.02
31.99%
-0.03
5.47%
-0.12
354.49%
-0.04
63.56%
-0.09
122.10%
-0.03
64.62%
-0.05
37.86%
-0.04
22.05%
-0.02
40.67%
0.00
108.27%
graham net net
1.61
-
11.62
623.40%
14.49
24.67%
3.52
75.67%
16.43
366.13%
8.33
49.33%
5.86
29.63%
-3.42
158.40%
-3.46
0.97%
-10.43
201.88%
-10.57
1.38%
graham number
11.97
-
37.10
209.93%
34.21
7.79%
34.04
0.48%
48.78
43.28%
46.95
3.74%
49.02
4.39%
38.53
21.40%
28.36
26.38%
16.49
41.86%
11.84
28.23%
income quality
0.77
-
0.46
40.27%
0.65
41.87%
0.75
15.07%
0.78
3.93%
0.74
5.25%
0.31
57.47%
0.72
128.03%
0.75
5.01%
0.48
36.40%
-0.24
149.44%
intangibles to total assets
0
-
-0.52
Infinity%
0
100%
0
0
0
0
0
0
0.07
Infinity%
0.18
144.22%
interest coverage
-86.94
-
-158.26
82.02%
-50.52
68.08%
-51.11
1.16%
-40.87
20.03%
-27.84
31.88%
-9.80
-
-4.95
49.46%
-5.03
1.59%
-2.33
53.75%
interest debt per share
0.06
-
-0.32
599.95%
0.15
146.21%
1.98
1,223.36%
0.59
70.38%
1.21
106.66%
5.31
337.11%
5.27
0.76%
9.63
82.81%
12.13
25.98%
20.50
69.00%
inventory turnover
0.07
-
0.44
494.05%
0.85
90.12%
1.14
35.07%
1.31
14.61%
3.48
166.00%
invested capital
0.01
-
-0.03
363.14%
0.01
118.70%
0.18
3,197.03%
0.02
86.78%
0.07
207.57%
0.40
465.04%
0.51
27.22%
1.70
230.70%
-8.34
591.99%
-11.06
32.50%
market cap
3.96B
-
7.20B
82.05%
7.91B
9.74%
3.20B
59.47%
11.50B
259.00%
7.33B
36.25%
12.58B
71.58%
14.94B
18.76%
20.09B
34.41%
28.92B
43.97%
23.91B
17.33%
net current asset value
208.45M
-
882.86M
323.54%
1.24B
40.10%
646.65M
47.72%
1.55B
140.40%
936.48M
39.76%
777.49M
16.98%
-230.99M
129.71%
-186.32M
19.34%
-1.01B
443.33%
-1.07B
5.48%
net debt to ebitda
0.57
-
-24.13
4,317.70%
4.33
117.94%
0.10
97.63%
1.23
1,097.83%
0.47
62.04%
0.26
44.54%
-0.03
112.32%
-0.25
684.84%
-0.51
102.58%
-8.20
1,515.46%
net income per share
-1.45
-
-4.85
234.71%
-3.45
28.82%
-4.79
38.73%
-5.42
13.14%
-7.57
39.65%
-8.11
7.13%
-7.46
7.96%
-7.20
3.54%
-9.30
29.11%
-3.52
62.08%
operating cash flow per share
-1.12
-
-2.23
99.92%
-2.25
0.98%
-3.59
59.64%
-4.23
17.59%
-5.59
32.31%
-2.55
54.44%
-5.35
109.88%
-5.42
1.29%
-4.45
17.89%
0.83
118.75%
payables turnover
0.03
-
0.50
1,564.69%
1.50
198.96%
1.91
27.07%
1.72
9.83%
5.59
224.87%
receivables turnover
11.10
-
1.27
88.60%
4.95
291.20%
2.02
59.19%
2.64
30.84%
3.99
51.00%
5.11
27.95%
4.81
5.81%
4.25
11.65%
4.36
2.53%
5.58
27.94%
research and ddevelopement to revenue
2.39
-
3.76
57.12%
6.73
78.80%
8.11
20.52%
4.34
46.42%
6.75
55.30%
2.98
55.82%
1.33
55.43%
0.94
29.38%
0.85
9.28%
0.55
35.46%
return on tangible assets
-0.21
-
-0.22
3.62%
-0.21
4.84%
-0.32
55.23%
-0.25
24.23%
-0.48
96.50%
-0.37
23.49%
-0.25
31.91%
-0.23
7.08%
-0.34
47.25%
-0.14
59.22%
revenue per share
0.77
-
0.68
11.17%
0.49
28.12%
0.55
12.60%
0.99
80.22%
0.74
25.00%
2.01
170.07%
4.29
113.12%
7.13
66.29%
8.53
19.61%
14.64
71.70%
roe
-0.33
-
-0.38
16.63%
-0.23
40.42%
-0.45
94.31%
-0.28
37.65%
-0.58
110.47%
-0.62
5.31%
-0.84
37.12%
-1.45
71.67%
7.15
593.08%
2.00
72.09%
roic
-0.33
-
-0.40
21.32%
-0.21
46.87%
-0.37
73.89%
-0.26
29.13%
-0.58
122.95%
-0.40
30.75%
-0.45
9.91%
-0.37
16.46%
-0.54
44.64%
-0.12
78.36%
sales general and administrative to revenue
0.58
-
0.88
52.98%
1.47
67.47%
1.89
28.47%
2.22
17.03%
5.10
130.20%
2.18
57.30%
1.19
45.23%
0.74
38.43%
0.74
1.06%
0.44
41.42%
shareholders equity per share
4.39
-
12.60
186.98%
15.06
19.46%
10.75
28.60%
19.51
81.45%
12.94
33.65%
13.17
1.73%
8.84
32.88%
4.97
43.81%
-1.30
126.18%
-1.77
35.86%
stock based compensation to revenue
0.44
-
0.65
48.97%
1.11
70.37%
1.60
43.76%
1.03
35.54%
2.11
104.00%
0.80
62.22%
0.28
64.33%
0.20
30.84%
0.22
13.27%
0.12
45.46%
tangible asset value
270.35M
-
1.50B
453.33%
1.26B
15.46%
920.22M
27.24%
1.77B
91.96%
1.30B
26.29%
1.44B
10.50%
1.02B
29.36%
588.20M
42.12%
-422.79M
171.88%
-918.43M
117.23%
tangible book value per share
4.39
-
12.60
186.98%
15.06
19.46%
10.75
28.60%
19.51
81.45%
12.94
33.65%
13.17
1.73%
8.84
32.88%
4.97
43.81%
-3.47
169.97%
-7.35
111.64%
working capital
208.45M
-
882.86M
323.54%
1.24B
40.10%
796.65M
35.59%
1.58B
98.90%
966.48M
39.01%
777.49M
19.55%
1.03B
32.71%
1.68B
62.57%
1.92B
14.72%
2.01B
4.71%

All numbers in USD (except ratios and percentages)